coxsackievirus B6 RO-86/1/73


EVAg

Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
014V-02068
field isolate
Product Risk Group: 
Virus name: 

Storage conditions: 
Viral Storage Medium -20C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Contains mycoplasmae - A protocol to remove mycoplasmae is provided

Unit definition: 
1 vial

In stock

1 000,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
This virus was isolated in Romania when the trivalent oral polio vaccine was in use. Therefore, it is considered as an OPV2/Sabin 2 potentially infected material and must be handled in compliance with the WHO GUIDANCE FOR NON-POLIOVIRUS FACILITIES TO MINIMIZE RISK OF SAMPLE COLLECTIONS POTENTIALLY INFECTIOUS FOR POLIOVIRUSES available at http://polioeradication.org/polio-today/preparing-for-a-polio-free-world/containment/containment-resources/.
Virus host type: 
Infectivity Test: 
Polio laboratory manual, 4th edition, 2004, World Health Organization, Geneva, Switzerland
Viral titer: 
10^6.6 TCID50/mL
Production cell line: 
Virus Cultivability: 
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Biological material origin: 
Natural origin
Collection date: 
Monday, 1 January, 1973
Country of collection: 
Suspected epidemiological origin : 
Isolation host: 
Isolation technique: 
cell culture